Under hypoxia condition, cancer cells were insensitive to sorafenib treatment, while, gain of ATAD3A expression mitigated the insensitivity as indicated by the fewer colonies (Fig. 3e, f) and increased apoptotic index in LM3 cells (Fig. 3g, h). Here, ATAD3A is linked to cancer.